SOURCE: Predictive Technology Group, Inc.


December 20, 2016 09:15 ET

Predictive Technology Group, Inc. (PRED) Retains Stevenson & Company CPAs

Stevenson & Company CPAs will act as independent auditors of Predictive Technology Group, Inc.

SALT LAKE CITY, UT--(Marketwired - December 20, 2016) - Predictive Technology Group, Inc. (OTC PINK: PRED), a life sciences technology holding company, announces the Company has retained Stevenson & Company CPAs as its PCAOB auditing firm.

Stevenson & Company CPAs will act as independent auditors as required to become a fully reporting company under US SEC rules.

Upon completion of the audited financial statements and other legal narratives required to become fully reporting, the Company will transmit its registration statement to the US SEC for approval.

For further information, contact Rich Kaiser, Investor Relations, YES INTERNATIONAL, 757-306-6090, and

About Predictive Technology Group, Inc.

Predictive Technology Group, Inc. (PRED), through its wholly owned subsidiaries, revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company develops and/or acquires proprietary technologies that open windows into the origin of human disease and the role that genes and their related proteins play in diseases' onsets and progressions. PRED's subsidiaries use gene-based information as cornerstones in the development of new diagnostics that assess a person's risk of disease and therapeutic products designed to effectively prevent and/or treat diseases.

Forward-Looking Statements

To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new vaccines and other pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment and other risks the Company may identify from time to time in the future. The Company does not undertake any obligation to provide an update with respect to any potential legal or financial transactions, except as required under applicable law.

Image Available:

Contact Information